Two Sigma Advisers’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-76,100
| Closed | -$1.79M | – | 2435 |
|
|
2024
Q4 | $1.79M | Buy |
76,100
+15,400
| +25% | +$363K | ﹤0.01% | 1169 |
|
|
2024
Q3 | $2.18M | Sell |
60,700
-63,300
| -51% | -$2.27M | 0.01% | 1020 |
|
|
2024
Q2 | $4.38M | Buy |
124,000
+110,400
| +812% | +$3.9M | 0.01% | 819 |
|
|
2024
Q1 | $386K | Sell |
13,600
-4,400
| -24% | -$125K | ﹤0.01% | 1975 |
|
|
2023
Q4 | $239K | Sell |
18,000
-33,600
| -65% | -$447K | ﹤0.01% | 2178 |
|
|
2023
Q3 | $462K | Sell |
51,600
-109,300
| -68% | -$979K | ﹤0.01% | 1818 |
|
|
2023
Q2 | $1.81M | Sell |
160,900
-75,600
| -32% | -$851K | ﹤0.01% | 1257 |
|
|
2023
Q1 | $2.72M | Buy |
236,500
+129,200
| +120% | +$1.49M | 0.01% | 1106 |
|
|
2022
Q4 | $1.24M | Buy |
107,300
+67,300
| +168% | +$780K | ﹤0.01% | 1473 |
|
|
2022
Q3 | $508K | Buy |
40,000
+15,700
| +65% | +$199K | ﹤0.01% | 1835 |
|
|
2022
Q2 | $167K | Sell |
24,300
-24,200
| -50% | -$166K | ﹤0.01% | 2310 |
|
|
2022
Q1 | $468K | Sell |
48,500
-1,400
| -3% | -$13.5K | ﹤0.01% | 2019 |
|
|
2021
Q4 | $593K | Buy |
49,900
+22,500
| +82% | +$267K | ﹤0.01% | 1837 |
|
|
2021
Q3 | $445K | Buy |
27,400
+1,500
| +6% | +$24.4K | ﹤0.01% | 1974 |
|
|
2021
Q2 | $545K | Sell |
25,900
-10,400
| -29% | -$219K | ﹤0.01% | 1914 |
|
|
2021
Q1 | $564K | Buy |
36,300
+11,900
| +49% | +$185K | ﹤0.01% | 1961 |
|
|
2020
Q4 | $512K | Buy |
+24,400
| New | +$512K | ﹤0.01% | 1855 |
|